CO2018001628A2 - Composiciones y formulaciones antimicrobianas - Google Patents

Composiciones y formulaciones antimicrobianas

Info

Publication number
CO2018001628A2
CO2018001628A2 CONC2018/0001628A CO2018001628A CO2018001628A2 CO 2018001628 A2 CO2018001628 A2 CO 2018001628A2 CO 2018001628 A CO2018001628 A CO 2018001628A CO 2018001628 A2 CO2018001628 A2 CO 2018001628A2
Authority
CO
Colombia
Prior art keywords
compositions
phase
antimicrobial formulations
enzyme
substrate
Prior art date
Application number
CONC2018/0001628A
Other languages
English (en)
Inventor
Sophie Constance Cox
Thomas Jon Hall
Liam Michael Grover
Rami Salib
Thomas Patton
James Brennan
John Reginald Barrett
Ian Staples
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1513045.3A external-priority patent/GB201513045D0/en
Application filed by Matoke Holdings Ltd filed Critical Matoke Holdings Ltd
Publication of CO2018001628A2 publication Critical patent/CO2018001628A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen composiciones para generar actividad antimicrobiana. Las composiciones comprende: una primera fase; una segunda fase; una enzima que es capaz de convertirse a un sustrato para liberar peróxido de hidrógeno; y una sustancia que incluye un sustrato para la enzima, en donde la primera fase y la segunda fase no son miscibles. Las composiciones pueden formularse como coloides, suspensiones o emulsiones, especialmente como cremas o rocíos. Se describen métodos para hacer las composiciones, así como su uso para el tratamiento de infecciones microbianas.
CONC2018/0001628A 2015-07-23 2018-02-20 Composiciones y formulaciones antimicrobianas CO2018001628A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1513045.3A GB201513045D0 (en) 2015-07-23 2015-07-23 Antimicrobial compositions and formulations
GB201606249 2016-04-12
PCT/GB2016/052258 WO2017013448A1 (en) 2015-07-23 2016-07-22 Antimicrobial compositions and formulations releasing hydrogen peroxide

Publications (1)

Publication Number Publication Date
CO2018001628A2 true CO2018001628A2 (es) 2018-11-22

Family

ID=56555490

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0001628A CO2018001628A2 (es) 2015-07-23 2018-02-20 Composiciones y formulaciones antimicrobianas

Country Status (16)

Country Link
US (1) US20180318399A1 (es)
EP (1) EP3324998A1 (es)
JP (1) JP2018527320A (es)
KR (1) KR20180051501A (es)
CN (1) CN107847566A (es)
AU (1) AU2016296150A1 (es)
BR (1) BR112018001279A2 (es)
CA (1) CA2990326A1 (es)
CO (1) CO2018001628A2 (es)
GB (1) GB2556567A (es)
HK (1) HK1256251A1 (es)
MA (1) MA42910A (es)
MX (1) MX2018001002A (es)
PH (1) PH12018500374A1 (es)
RU (1) RU2018105622A (es)
WO (1) WO2017013448A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111713498B (zh) 2014-04-30 2023-07-07 玛托克控股有限公司 抗微生物组合物
WO2018065789A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
US20200069777A1 (en) * 2016-11-15 2020-03-05 Matoke Holdings Limited Antimicrobial compositions and formulations
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2019077336A1 (en) * 2017-10-16 2019-04-25 Matoke Holdings Limited DOUBLE DISTRIBUTOR CONTAINING WATER AND ANTIMICROBIAL COMPOSITION
CN107668320A (zh) * 2017-11-03 2018-02-09 杭州市农业科学研究院 以蜂蜜为原料的饲料添加剂及其制备方法
WO2020022989A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for baby skin care
CN110734563B (zh) * 2018-07-20 2022-05-17 南京理工大学 细菌纤维素/鸸鹋油复合膜及其制备方法
WO2020193993A2 (en) 2019-03-27 2020-10-01 Matoke Holdings Limited Antimicrobial compositions
CN111631271A (zh) * 2020-05-22 2020-09-08 南昌大学 一种稳定w/o/w型多重乳液的制备方法
WO2023227599A1 (en) * 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
FR2769504B1 (fr) * 1997-10-13 2000-03-10 Oreal Utilisation du miel en tant qu'agent diminuant l'adhesion des micro-organismes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
AU2003234758B2 (en) * 2002-08-13 2009-04-02 Derma Sciences, Inc. Composition
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料
CN107708752A (zh) * 2015-02-03 2018-02-16 玛托克控股有限公司 抗微生物纤维和组合物

Also Published As

Publication number Publication date
RU2018105622A3 (es) 2020-02-21
GB201801667D0 (en) 2018-03-21
CN107847566A (zh) 2018-03-27
CA2990326A1 (en) 2017-01-26
RU2018105622A (ru) 2019-08-27
MA42910A (fr) 2018-05-30
HK1256251A1 (zh) 2019-09-20
AU2016296150A1 (en) 2018-03-01
JP2018527320A (ja) 2018-09-20
GB2556567A (en) 2018-05-30
KR20180051501A (ko) 2018-05-16
MX2018001002A (es) 2018-09-28
PH12018500374A1 (en) 2018-08-20
BR112018001279A2 (pt) 2018-09-11
WO2017013448A1 (en) 2017-01-26
EP3324998A1 (en) 2018-05-30
US20180318399A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
CO2018001628A2 (es) Composiciones y formulaciones antimicrobianas
UY37563A (es) Aislados de bacillus y usos de los mismos
CO2017007694A2 (es) Composiciones de bacillus licheniformis rti184 para beneficiar el crecimiento de plantas
CL2017001923A1 (es) Derivados de 9h-pirrolo-dipiridina
UY34605A (es) Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
BR112017027147A2 (pt) agente estimulante de restauração/crescimento de cabelo
CO2019006673A2 (es) Polimorfos
CL2017002856A1 (es) Compuestos de tioéter como inhibidores de la nitrificación
EA201692334A1 (ru) Кортикостероидные композиции для местного применения
CL2019001737A1 (es) Polimorfos.
CR20160433A (es) Nuevos compuestos
MX2020003495A (es) Derivados de acido boronico y sintesis de los mismos.
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2016000007A (es) Pirazolpiridinas sustituidas
MX2016013894A (es) Composicion para el cuidado del cuero cabelludo.
DOP2016000268A (es) Compuestos de azol amido–sustituidos como inhibidores de tnks1 y/o tnks2
CO2022002898A2 (es) Composiciones que comprenden tigolaner para el control de parásitos
EA202090732A1 (ru) Составы для трансдермального введения
NI202000042A (es) Polimorfos
MX368582B (es) Extracto de gardenia para colorear la piel.
AR109409A1 (es) Compuesto de 3-piridiloxifenildihidrouracilo y su uso
AR109407A1 (es) Compuesto de 1-acetil-3-fenilurea y su uso
UY37444A (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso
CL2020000586A1 (es) Moduladores de la expresión de enac.